首页> 外文期刊>Biotechnology Law Report >Former InterMune CEO Convicted of Wire Fraud; Further Troubles for Sequenom: Investigations, Shareholder Lawsuit Follow Alleged Mishandling of Data on Fetal Test; Amgen Sued over Aranesp Sales Practices; ZymoGenetics Can Resume Marketing Campaign; Congressional Members Request Drug Price Inquiries; Steps Forward in Decode Bankruptcy Case
【24h】

Former InterMune CEO Convicted of Wire Fraud; Further Troubles for Sequenom: Investigations, Shareholder Lawsuit Follow Alleged Mishandling of Data on Fetal Test; Amgen Sued over Aranesp Sales Practices; ZymoGenetics Can Resume Marketing Campaign; Congressional Members Request Drug Price Inquiries; Steps Forward in Decode Bankruptcy Case

机译:InterMune前首席执行官被判犯有电汇欺诈罪; Sequenom的其他麻烦:调查,股东诉讼遵循指控的胎儿测试数据处理不当; Amgen因Aranesp销售惯例被起诉; ZymoGenetics可以恢复营销活动;国会议员要求查询药品价格;解码破产案中的步骤

获取原文
获取原文并翻译 | 示例
       

著录项

  • 来源
    《Biotechnology Law Report》 |2009年第6期|p.729-731|共3页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号